Skip to main content
NASDAQ:MOHO

ECMOHO Competitors

$1.69
+0.09 (+5.63 %)
(As of 05/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.60
$1.75
50-Day Range
$1.60
$2.14
52-Week Range
$1.29
$3.98
Volume184,615 shs
Average Volume80,693 shs
Market Capitalization$58.61 million
P/E RatioN/A
Dividend YieldN/A
Beta1.2

Competitors

ECMOHO (NASDAQ:MOHO) Vs. AMZN, W, CHWY, CDW, VIPS, and OZON

Should you be buying MOHO stock or one of its competitors? Companies in the industry of "catalog & mail-order houses" are considered alternatives and competitors to ECMOHO, including Amazon.com (AMZN), Wayfair (W), Chewy (CHWY), CDW (CDW), Vipshop (VIPS), and Ozon (OZON).

Amazon.com (NASDAQ:AMZN) and ECMOHO (NASDAQ:MOHO) are both retail/wholesale companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, institutional ownership, dividends, valuation and risk.

Risk & Volatility

Amazon.com has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500. Comparatively, ECMOHO has a beta of 1.2, meaning that its stock price is 20% more volatile than the S&P 500.

Insider and Institutional Ownership

56.4% of Amazon.com shares are owned by institutional investors. Comparatively, 0.4% of ECMOHO shares are owned by institutional investors. 16.1% of Amazon.com shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings and target prices for Amazon.com and ECMOHO, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Amazon.com014602.98
ECMOHO0000N/A

Amazon.com currently has a consensus target price of $4,180.5435, suggesting a potential upside of 29.71%. Given Amazon.com's higher probable upside, equities research analysts plainly believe Amazon.com is more favorable than ECMOHO.

Valuation & Earnings

This table compares Amazon.com and ECMOHO's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Amazon.com$280.52 billion5.79$11.59 billion$23.01140.07
ECMOHO$329.48 million0.18$2.30 millionN/AN/A

Amazon.com has higher revenue and earnings than ECMOHO.

Profitability

This table compares Amazon.com and ECMOHO's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Amazon.com4.99%24.49%7.04%
ECMOHO-4.28%-17.98%-8.29%

Summary

Amazon.com beats ECMOHO on 11 of the 12 factors compared between the two stocks.

ECMOHO (NASDAQ:MOHO) and Wayfair (NYSE:W) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, profitability, earnings and risk.

Risk and Volatility

ECMOHO has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, Wayfair has a beta of 3.43, indicating that its stock price is 243% more volatile than the S&P 500.

Insider and Institutional Ownership

0.4% of ECMOHO shares are owned by institutional investors. Comparatively, 81.3% of Wayfair shares are owned by institutional investors. 30.9% of Wayfair shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of current ratings and price targets for ECMOHO and Wayfair, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ECMOHO0000N/A
Wayfair3101602.45

Wayfair has a consensus target price of $317.4286, suggesting a potential upside of 5.81%. Given Wayfair's higher probable upside, analysts clearly believe Wayfair is more favorable than ECMOHO.

Valuation and Earnings

This table compares ECMOHO and Wayfair's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ECMOHO$329.48 million0.18$2.30 millionN/AN/A
Wayfair$9.13 billion3.40$-984,580,000.00($10.65)-28.17

ECMOHO has higher earnings, but lower revenue than Wayfair.

Profitability

This table compares ECMOHO and Wayfair's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ECMOHO-4.28%-17.98%-8.29%
Wayfair-5.35%N/A-18.55%

Summary

Wayfair beats ECMOHO on 8 of the 12 factors compared between the two stocks.

ECMOHO (NASDAQ:MOHO) and Chewy (NYSE:CHWY) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, profitability, earnings and risk.

Risk and Volatility

ECMOHO has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, Chewy has a beta of 0.26, indicating that its stock price is 74% less volatile than the S&P 500.

Insider and Institutional Ownership

0.4% of ECMOHO shares are owned by institutional investors. Comparatively, 97.6% of Chewy shares are owned by institutional investors. 0.4% of Chewy shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of current ratings and price targets for ECMOHO and Chewy, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ECMOHO0000N/A
Chewy161402.62

Chewy has a consensus target price of $92.5263, suggesting a potential upside of 36.57%. Given Chewy's higher probable upside, analysts clearly believe Chewy is more favorable than ECMOHO.

Valuation and Earnings

This table compares ECMOHO and Chewy's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ECMOHO$329.48 million0.18$2.30 millionN/AN/A
Chewy$4.85 billion5.80$-252,370,000.00($0.63)-107.54

ECMOHO has higher earnings, but lower revenue than Chewy.

Profitability

This table compares ECMOHO and Chewy's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ECMOHO-4.28%-17.98%-8.29%
Chewy-2.70%N/A-14.41%

Summary

Chewy beats ECMOHO on 8 of the 12 factors compared between the two stocks.

ECMOHO (NASDAQ:MOHO) and CDW (NASDAQ:CDW) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, profitability, earnings and risk.

Risk and Volatility

ECMOHO has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, CDW has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500.

Insider and Institutional Ownership

0.4% of ECMOHO shares are owned by institutional investors. Comparatively, 91.4% of CDW shares are owned by institutional investors. 1.3% of CDW shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of current ratings and price targets for ECMOHO and CDW, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ECMOHO0000N/A
CDW10502.67

CDW has a consensus target price of $172.8571, suggesting a potential upside of 2.01%. Given CDW's higher probable upside, analysts clearly believe CDW is more favorable than ECMOHO.

Valuation and Earnings

This table compares ECMOHO and CDW's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ECMOHO$329.48 million0.18$2.30 millionN/AN/A
CDW$18.03 billion1.32$736.80 million$6.0228.15

CDW has higher revenue and earnings than ECMOHO.

Profitability

This table compares ECMOHO and CDW's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ECMOHO-4.28%-17.98%-8.29%
CDW4.08%88.43%10.72%

Summary

CDW beats ECMOHO on 11 of the 12 factors compared between the two stocks.

ECMOHO (NASDAQ:MOHO) and Vipshop (NYSE:VIPS) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, profitability, earnings and risk.

Risk and Volatility

ECMOHO has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, Vipshop has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500.

Valuation and Earnings

This table compares ECMOHO and Vipshop's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ECMOHO$329.48 million0.18$2.30 millionN/AN/A
Vipshop$13.36 billion1.28$576.98 million$0.9227.43

Vipshop has higher revenue and earnings than ECMOHO.

Analyst Ratings

This is a summary of current ratings and price targets for ECMOHO and Vipshop, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ECMOHO0000N/A
Vipshop10602.71

Vipshop has a consensus target price of $30.1250, suggesting a potential upside of 19.35%. Given Vipshop's higher probable upside, analysts clearly believe Vipshop is more favorable than ECMOHO.

Insider and Institutional Ownership

0.4% of ECMOHO shares are owned by institutional investors. Comparatively, 49.4% of Vipshop shares are owned by institutional investors. 29.5% of Vipshop shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares ECMOHO and Vipshop's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ECMOHO-4.28%-17.98%-8.29%
Vipshop5.16%19.76%9.85%

Summary

Vipshop beats ECMOHO on 11 of the 12 factors compared between the two stocks.

ECMOHO (NASDAQ:MOHO) and Ozon (NASDAQ:OZON) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, risk and valuation.

Valuation & Earnings

This table compares ECMOHO and Ozon's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ECMOHO$329.48 million0.18$2.30 millionN/AN/A
OzonN/AN/AN/AN/AN/A

ECMOHO has higher revenue and earnings than Ozon.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for ECMOHO and Ozon, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ECMOHO0000N/A
Ozon03302.50

Ozon has a consensus price target of $51.00, suggesting a potential downside of 8.65%. Given Ozon's higher possible upside, analysts plainly believe Ozon is more favorable than ECMOHO.

Insider & Institutional Ownership

0.4% of ECMOHO shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares ECMOHO and Ozon's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ECMOHO-4.28%-17.98%-8.29%
OzonN/AN/AN/A

Summary

Ozon beats ECMOHO on 5 of the 7 factors compared between the two stocks.


ECMOHO Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Amazon.com logo
AMZN
Amazon.com
1.9$3,222.90+1.9%$1.63 trillion$280.52 billion94.37Analyst Report
Insider Selling
Wayfair logo
W
Wayfair
1.5$300.00+1.6%$31.07 billion$9.13 billion-42.98Analyst Upgrade
Chewy logo
CHWY
Chewy
1.8$67.75+3.1%$28.13 billion$4.85 billion-157.55News Coverage
Gap Down
CDW logo
CDW
CDW
1.9$169.45+0.5%$23.76 billion$18.03 billion33.42Analyst Report
Vipshop logo
VIPS
Vipshop
1.7$25.24+4.9%$17.13 billion$13.36 billion24.27Upcoming Earnings
News Coverage
Gap Down
OZON
Ozon
0.7$55.83+3.5%$11.37 billionN/A0.00Upcoming Earnings
News Coverage
Qurate Retail logo
QRTEA
Qurate Retail
1.7$13.20+0.9%$5.42 billion$13.46 billion8.15Earnings Announcement
Insider Selling
Stitch Fix logo
SFIX
Stitch Fix
1.8$43.06+4.6%$4.58 billion$1.71 billion-75.54Analyst Upgrade
News Coverage
Gap Down
Insight Enterprises logo
NSIT
Insight Enterprises
1.2$100.70+1.3%$3.56 billion$7.73 billion22.04
Revolve Group logo
RVLV
Revolve Group
1.4$47.22+7.3%$3.38 billion$600.99 million72.65Analyst Downgrade
Insider Selling
Gap Down
Overstock.com logo
OSTK
Overstock.com
1.7$71.14+5.9%$3.06 billion$1.46 billion338.78Gap Down
Jumia Technologies logo
JMIA
Jumia Technologies
0.9$25.98+11.1%$2.56 billion$180.10 million-7.62Analyst Upgrade
Gap Down
Baozun logo
BZUN
Baozun
2.3$32.26+4.5%$2.51 billion$1.05 billion40.84Upcoming Earnings
Gap Down
PC Connection logo
CNXN
PC Connection
1.6$48.53+4.2%$1.27 billion$2.82 billion20.92Gap Down
LightInTheBox logo
LITB
LightInTheBox
0.9$2.84+3.2%$318.29 million$243.63 million21.85
RUHN
Ruhnn
0.4$3.40+0.0%$281.03 million$183.01 million-18.89
iMedia Brands logo
IMBI
iMedia Brands
1.3$7.41+6.7%$121.41 million$501.82 million-2.18Gap Down
Blue Apron logo
APRN
Blue Apron
1.7$4.32+5.6%$77.19 million$454.87 million-1.07Gap Down
This page was last updated on 5/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.